Bernard Roubert

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Maria Domenica Cappellini, John B. Porter, Amal El‐Beshlawy et al. · Haematologica · 2009 · 287 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia

Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini et al. · Blood · 2009 · 194 citations · Full text

Medicine, Cardiology, Hematology +12

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

Norbert Gattermann, Carlo Finelli, Matteo Giovanni Della Porta et al. · Leukemia Research · 2010 · 177 citations

Medicine, Hematology, Internal Medicine +15

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

N. Gattermann, Carlo Finelli, Matteo Giovanni Della Porta et al. · Haematologica · 2012 · 170 citations · Full text

Medicine, Hematology, Internal Medicine +17

Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with  -thalassemia major

Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini et al. · Haematologica · 2012 · 138 citations · Full text

Medicine, Cardiology, Pharmacology +17